GJA1 and epilepsy: Augmented Cx43 protein levels were confirmed by other research groups (in epilepsy associated brain tumors [66,67], in (mesial) temporal lobe epilepsy ((M)TLE) [67,68,69,70], in epilepsy secondary to focal cortical dysplasia (FCD) type IIB [71], and in epileptic foci of refractory seizures [72]).